ENDO in Biological Technology
Navigation Links
ENDO in Biological Technology
Jubilant to Work With Endo Pharmaceuticals on Drug Development
NOIDA, India, June 11 /PRNewswire/ -- - Collaboration to Provide Endo Pharmaceuticals With New Drug Candidates in Oncology Jubilant Organosys Ltd., headquartered in Noida, announced today that its Bangalore-based subsidiary, Jubilant Biosys Ltd., has entered into a discovery and ...SAN FRANCISCO, Nov. 20 /PRNewswire/ -- WWMR, Inc., the marketing research leader in pain, announces results of the first annual "Most Appreciated Pain Drug Company Survey". The top three most appreciated companies are Pfizer, Eli Lilly and Endo Pharmaceuticals, according to the 100 pain clinic ph...
Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
Investor Conference Call Scheduled for December 28, 2007 at 8:30 a.m Eastern Time PALO ALTO, Calif., Dec. 27 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced that it has initiated a license and development partnership with E...Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
...HADDS FORD, Pa., July 30 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today reported f...of results of Indevus Pharmaceuticals, Inc., which endo acquired during the first quarter. Total re...IN PRODUCTS LIDODERM ((R)) : In September, endo will celebrate the tenth anniversary of the FDA ap...Endocare and Galil Medical Announce Settlement of Litigation
... IRVINE, Calif. and YOKNEAM, Israel, July 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ) and privately-held Galil Medical Ltd., today announced that they have entered into a settlement agreement stipulating to termination of the previous...AEterna Zentaris Acquires All Assets from Ardana for Growth Hormone Secretagogue Compound, AEZS-130
...e interest of potential strategic partners for this project as we have already initiated partnering discussions." AEZS-130 Poster Presentation at endo The poster #P2-749 entitled, "Use of an oral GHS ghrelin-mimetic GHS as a simple diagnostic test for adult GH deficiency", G.R. Merriam, K.C.J. Y...Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
...ADDS FORD, Pa., March 30 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...aboratories. Her appointment brings the number of endo board members to nine. Roger Kimmel, chairman of the board of endo Pharmaceuticals, stated: "We are pleased to have ......ADDS FORD, Pa., March 16 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...evus Pharmaceuticals, Inc. (Nasdaq: IDEV ). endo has extended the subsequent offering period for al.... New York City time on Wednesday, March 18, 2009. endo and BTB do not intend to further extend the subseq...
...HADDS FORD, Pa., Feb. 23 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today announced ..., the depositary for the tender offer, has advised endo that, as of 5:00 p.m., New York City time, on Febr...tendered shares have been accepted for payment and endo will pay for all such shares promptly. ...
...estructuring includes a workforce reduction of 52 employees, representing approximately 33% of the Company's total workforce. In addition, Alexza and endo Pharmaceuticals, Inc. have agreed to mutually terminate their development agreement for AZ-003 (Staccato fentanyl), a product development candidate th...
...eland Clinic Medical Innovation Summit. Cambridge endo developed, manufactures and markets the innovative...rge addressable market." About Cambridge endo Cambridge endo is a privately held medical device company that de...
...HADDS FORD, Pa., Jan. 28 /PRNewswire-FirstCall/ -- endo Pharmaceuticals Inc. (Nasdaq: ENDP ), will annou...nvestor Relations section of the website. About endo endo Pharmaceuticals is a specialty pharmaceutical comp...
Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
...CHADDS FORD, Pa., Jan. 9 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...Webcast of the presentation may be accessed on the endo Website at www.endo.com . The presentation will be archived for ninety days. About endo Pharmaceuticals ...38 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting
... IRVINE, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologis...Endocare Reports Financial Results for Third Quarter 2008
...d to Prior Year; Operating Loss Declines 26% IRVINE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologis...DURECT Corporation Announces Third Quarter 2008 Financial Results
...ur proprietary transdermal patch intended to deliver bupivacaine for a period of up to three days from a single application. -- TRANSDUR-Sufentanil. endo Pharmaceuticals, our licensee for commercialization of TRANSDUR-Sufentanil in the US and Canada, has stated that they expect to have data from a Phase...ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
...nancial reporting, tax, treasury, and strategic financial planning. Most recently, he was the executive vice president and chief financial officer for endo Pharmaceuticals, as well serving for a period as co-interim chief executive officer. At Endo, Mr. Rowland drove the strategic planning process through...Best Practices Document on Cryoablation Posted on Website of American Urological Association
... IRVINE, Calif., Sept. 23 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced today t...Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation
... Phase 2 testing. Product candidates in Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releas...Autonomy(TM) Lapro-Angle(TM) Articulating Laparoscopic Instruments Granted CE Mark
...s exciting technique to their patients." About Cambridge Endo Cambridge endo is a privately held medical device company that designs, develops and manuf... surgeons, gynecologic surgeons and other surgical specialties. Cambridge endo is headquartered in Framingham, MA. For more information about Cambridge, p...... Phase 2 testing. Product candidates in Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releas...
... Phase 2 testing. Product candidates in Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releas...
...nagement of marketing activities for Integrilin(R) (eptifibatide), a best in class antithrombotic drug. Previously, at Rhone Poulenc Rorer and Ethicon endo Surgery he was involved in the launch and commercialization of several products, including Lovenox(R) (enoxaparin). He holds a B.S. in Finance from th...
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...: ABC ) APP PHARMACEUTICALS INC (NASDAQ: APPX ) CEPHALON INC (NASDAQ: CEPH ) CHARLES RIV LABS INTL INC (NYSE: CRL ) COVANCE INC (NYSE: CVD ) endo PHARMACEUTICALS HLDGS INC (NASDAQ: ENDP ) HOSPIRA INC (NYSE: HSP ) INVENTIV HEALTH INC (NASDAQ: VTIV ) OMNICARE INC (NYSE: OCR ) PAREXEL INTL ...'Breakthroughs Ahead,' Endocrine Society Tells Security Analysts
...rnational association focused on endocrinological research and practice, today hosted a teleconference for security analysts. The call originated from endo 08, the annual conference of the Society, which is now being held in San Francisco. The Society has over 14,000 members from 80 countries, many of who...WWMR, Inc. Announces Launch of New Pain Clinic Monitor
...eNeS Pharmaceuticals, Purdue Pharma, DOV, Reckitt Benckiser/Vernalis, Durect, Rinat Neuroscience/Pfizer, Elan Pharm, Roche, Eli Lilly, Sanofi-Aventis, endo Pharm, Schwarz, Forest Laboratories, Sosei R&D, Gedeon Richter, Teikoku Seiyaku, GlaxoSmithKline, TheraQuest, Grunenthal, Vernalis, GW Pharmaceuticals...Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates
...uct candidate under the development agreement with endo Pharmaceuticals, increased spending for device dev...l). Alexza is jointly developing AZ-003 with endo Pharmaceuticals Inc. for the treatment of breakthr...ough pain in cancer and non-cancer patients. endo is responsible for regulatory, pre-clinical a...Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
...ts Board of Directors. The appointment increases Board membership to eight. Holveck, 62, is the President, Chief Executive Officer and a Director of endo Pharmaceuticals. He is the former President of Johnson & Johnson Development Corp. and a Vice President of Corporate Development with Johnson & Johnso......se 2 testing. Product candidates in Phase 1 testing include AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releas...
... Medical Optics, Inc. (NYSE: EYE ) Align Technology Inc. (Nasdaq: ALGN ) Array Biopharma Inc. (Nasdaq: ARRY ) ArthroCare Corp. (Nasdaq: ARTC ) endo Pharmaceuticals Hldgs. (Nasdaq: ENDP ) Fresenius Medical Care AG (XETRA: FME.DE) GEDEON RICHTER RT (XETRA: R1G1.DE) GENMAB A/S (Copenhagen: GEN.CO...
Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
...se 2 testing. Product candidates in Phase 1 testing include AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releas...Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
...) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. AZ- 003 (Staccato fentanyl), which is partnered with endo Pharmaceuticals in North America, for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia are in Phase 1 t...Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
...m) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. AZ-003 (Staccato fentanyl), which is partnered with endo Pharmaceuticals in North America, for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia are in Phase 1 t...DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results
...n full commercial rights to this drug candidate. -- TRANSDUR-Sufentanil. endo Pharmaceuticals, our licensee for commercialization in the US and Canad... our clinical and regulatory strategy. -- TRANSDUR-Sufentanil Patch. endo Pharmaceuticals is continuing to conduct Phase II studies with TRANSDUR...Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
...ating Shears, the TLS3, which uses the Company's innovative seal and divide technology. The award was presented during the 16th SLS Annual Meeting and endo Expo, September 5th in San Francisco. "We are pleased to be recognized for the second time by one of the leading organizations representing our custo...Other TagsBrothBrothBrothFltOther Contentspulmonarypulmonarypulmonarypulmonarypulmonarypulmonarypulmonarypyloricpyloricpyruvicpyruviclocilocilocilociquantitativequantitativequantitativequantitativequantitativequantitativequantitativequantitativequantitativesymmetrycanalcanalcanalcanalcanalcanal
(Date:11/23/2009)...y by the Wildlife Conservation Society says that w... the Republic of Congopart of the "mother lode" of...e becoming increasingly threatened by growing huma...s protection of the swamp forests adjacent to the ... recent surveys confirmed that high densities of t...
(Date:11/23/2009)...CT Current research suggests that a common oral b...elated report by Nichols et al, "Unique Lipids fro...f TLR2 Ligands Capable of Enhancing Autoimmunity,"...an Journal of Pathology . , Multiple sclerosis (... brain and spinal cord, affects nearly 1 in 700 pe...
(Date:11/23/2009)... - The only swine vaccine available for the H1N1 v...ted with the virus. The vaccination marks the firs...osed with the pandemic flu., Iowa State Universi...eloped the vaccine this summer and has been shippi...nsas and Illinois for several weeks., The latest...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Genetics of patterning the cerebral cortex 59356 1Genetics of patterning the cerebral cortex 59356 2Genetics of patterning the cerebral cortex 59356 3A new scan for lung diseases 59354 1A new scan for lung diseases 59354 2Canadian blood supply future uncertain as population ages 3A Study 59352 1Canadian blood supply future uncertain as population ages 3A Study 59352 2(Date:11/27/2009)...re-FirstCall/ -- The Gymboree Corporation (Nasdaq:...ll present at the NASDAQ OMX 23rd Investor Program...on, England, on Wednesday, December 2, 2009, at 11...of The Gymboree Corporation,s presentation over th...ck on "Our Company" at the bottom of the page, go ...
(Date:11/27/2009)... Shamir Optical Industry ...ider of innovative products and technology to the ...oard of directors had declared a dividend distribu...roximately NIS 37.62 million based on the November...roximately US$ 0.609 (approximately NIS 2.3 based ...
(Date:11/27/2009)...l, economic burdens, study predicts , , ...people with diabetes in the United States is expec...predicts. , That would bring the total by 2034 ...from 23.7 million today. , , At the same time, t...le, the study also warns, rising from an estimated...
(Date:11/27/2009)...ingual coloring books designed for children ages 2... to educate - inform parents and children alike on...uars to ABC,S and a host of other topics. , ...r 27, 2009 -- Today’s children have enough g...hour of the day, but one of the oldest and simples...
(Date:11/26/2009)...-- With cold and flu season upon us, it,s more imp...ol the spread of infections and avoid illness. ,...lves healthy, but to avoid transmitting illness if...rtified in infection-control), nursing director fo...pital for Special Surgery (HSS) in Manhattan. ,...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] Diabetes Cases Expected to Double in 25 Years[2] Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |